{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "GBp", "firstTradeDateMilliseconds": 1196236800000, "priceHint": 2, "epsTrailingTwelveMonths": -0.02, "sharesOutstanding": 582659008, "bookValue": 0.047, "fiftyDayAverage": 14.0425, "fiftyDayAverageChange": -1.3174992, "fiftyDayAverageChangePercent": -0.09382227, "twoHundredDayAverage": 17.5255, "twoHundredDayAverageChange": -4.800499, "twoHundredDayAverageChangePercent": -0.2739151, "marketCap": 75446656, "priceToBook": 270.7447, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChangePercent": -0.585936, "regularMarketPrice": 12.725, "marketState": "CLOSED", "exchange": "LSE", "shortName": "E-THERAPEUTICS PLC ORD 0.1P", "longName": "e-therapeutics plc", "messageBoardId": "finmb_23184200", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketChange": -0.07499981, "regularMarketTime": 1683904641, "regularMarketDayHigh": 13.2435, "regularMarketDayRange": "12.5 - 13.2435", "regularMarketDayLow": 12.5, "regularMarketVolume": 178793, "regularMarketPreviousClose": 12.8, "bid": 12.0, "ask": 13.45, "bidSize": 0, "askSize": 0, "fullExchangeName": "LSE", "financialCurrency": "GBP", "regularMarketOpen": 12.5595, "averageDailyVolume3Month": 203823, "averageDailyVolume10Day": 287677, "fiftyTwoWeekLowChange": 2.6750002, "fiftyTwoWeekLowChangePercent": 0.26616916, "fiftyTwoWeekRange": "10.05 - 24.0", "fiftyTwoWeekHighChange": -11.275, "fiftyTwoWeekHighChangePercent": -0.46979165, "fiftyTwoWeekLow": 10.05, "fiftyTwoWeekHigh": 24.0, "earningsTimestamp": 1683197940, "earningsTimestampStart": 1683197940, "earningsTimestampEnd": 1683197940, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "ETX.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4 Kingdom Street", "address2": "Floor 4 Unit 4B Paddington Central", "city": "London", "zip": "W2 6BD", "country": "United Kingdom", "phone": "44 20 4551 8888", "website": "https://www.etherapeutics.co.uk", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing. The company was incorporated in 2001 and is based in London, the United Kingdom.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Ahmad Ali Mortazavi", "age": 51, "title": "CEO & Director", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": {"raw": 270000, "fmt": "270k", "longFmt": "270,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1547654, "fmt": "1.55M", "longFmt": "1,547,654"}}, {"maxAge": 1, "name": "Mr. Michael Anthony Bretherton ACA, B.A.", "age": 67, "title": "Acting Interim CFO & Director", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": {"raw": 120000, "fmt": "120k", "longFmt": "120,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Laura  Roca-Alonso Ph.D.", "title": "Chief Operating & Bus. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Alan  Whitmore B.Sc., Ph.D.", "title": "Chief Scientific Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Sarah  Clare", "title": "Director of Fin. & Compliance", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Alison  Gallafent", "title": "Chief Intellectual Property Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Ankit  Sharma", "title": "Head of Software Engineering", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Graham  Craggs", "title": "Head of Therapeutic Discovery", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Timothy  Bretherton", "title": "Director of Fin. & Operations and Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400}}], "error": null}}